Stockreport

aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update [Yahoo! Finance]

aTyr Pharma, Inc.  (ATYR) 
PDF aTyr Pharma, Inc. Company scheduled to meet with the FDA in mid-April 2026 to review the results of the Phase 3 EFZO-FIT™ study and determine the path forward for efz [Read more]